An observational study of alemtuzumab following fingolimod for multiple sclerosis

Mark Willis, Owen Pearson, Zsolt Illes, Tobias Sejbaek, Christian Nielsen, Martin Duddy, Kate Petheram, Caspar van Munster, Joep Killestein, Clas Malmeström, Emma Tallantyre, Neil Robertson

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

158 Downloads (Pure)

Fingeraftryk

Dyk ned i forskningsemnerne om 'An observational study of alemtuzumab following fingolimod for multiple sclerosis'. Sammen danner de et unikt fingeraftryk.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience